Trinity Biotech plc TRIB
NASDAQ
Recommendation
Dividend Power Score
Day's Range
$7.51$7.96
Latest Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
--
EPS (TTM)
| 12/31/2025 | 06/30/2025 | 12/31/2024 | 09/30/2024 | ||
|---|---|---|---|---|---|
| Revenue | -- | -- | 61.56M | 59.13M | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | -- | -- | 61.56M | 59.13M | |
| Cost of Revenue | -- | -- | 40.12M | 38.00M | |
| Gross Profit | -- | -- | 21.44M | 21.13M | |
| SG&A Expenses | -- | -- | 28.81M | 27.38M | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -- | -- | 1.79M | -42.00K | |
| Total Operating Expenses | -- | -- | 75.26M | 69.54M | |
| Operating Income | -- | -- | -13.70M | -10.41M | |
| Income Before Tax | -- | -- | -30.73M | -20.43M | |
| Income Tax Expenses | -- | -- | 486.00K | -102.00K | |
| Earnings from Continuing Operations | -- | -- | -31.22 | -20.33 | |
| Earnings from Discontinued Operations | -- | -- | -573.00K | -3.00K | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | -- | -- | -31.79M | -20.33M | |
| EBIT | -- | -- | -13.70M | -10.41M | |
| EBITDA | -- | -- | -11.84M | -8.51M | |
| EPS Basic | -- | -- | -50.84K | -45.27 | |
| Normalized Basic EPS | -- | -- | -24.56 | -0.30 | |
| EPS Diluted | -- | -- | -51.34K | -45.79 | |
| Normalized Diluted EPS | -- | -- | -24.56 | -0.30 | |
| Average Basic Shares Outstanding | -- | -- | 1.40M | 36.38M | |
| Average Diluted Shares Outstanding | -- | -- | 2.10K | 1.82M | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |